RAPT Therapeutics, Inc. — Director's Dealing 2020

Jun 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2020-06-25

Reporting Person: Lam Karen C (VP, Finance & Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-25	Common Stock	S	875	$35.00	Disposed	12735	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2020.